NEW YORK (GenomeWeb) – HTG Molecular Diagnostics announced today that it has signed distribution agreements with Gamidor Diagnostics and Durviz s.l. Parque Tecnológico de Valencia to distribute its next-generation sequencing-based products in Israel, and Spain and Portugal, respectively. 

Gamidor sells diagnostic systems, chemicals, reagents, and services in Israel to hospitals, health management systems, and academic research institutes. Durviz distributes NGS reagents and library preparation systems in Spain and Portugal. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.